Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...

The pharmaceutical company Amgen is suing the Colorado Prescription Drug Affordability Board after the price of one of its drugs was capped.

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price ...

The Financial Times covers significant financial stories. EQT considers acquiring German marketplace Mobile.de. Delaware's attorney-general warns OpenAI over public interest. Aquarian Holdings ...

Plus, how a little-known Utah lender became First Brands’ biggest creditor and Novo Nordisk gatecrashes Pfizer’s latest deal ...

Call him the Pharmacist-in-Chief. President Donald Trump last week announced the launch of TrumpRx, a website where Americans will be able to find discounted medicine. It is part of a “sweeping deal” ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

Bipartisan Cost Coalition backs Rep. Mikie Sherrill's New Jersey gubernatorial campaign, citing her affordability plans over ...

Get live updates and the latest news as the government shutdown hits the one month mark, with Trump administration promising ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.